CEO, Bioquark Inc.
Topic:- Accessing Nature’s Clues For Human Regeneration, Disease Reversion and Rejuvenation
Ira Pastor, CEO, Bioquark Inc. (www.bioquark.com) a U.S. life sciences company focused on biologic solutions for human regeneration, disease reversion, and age rejuvenation – 30+ years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, and retail – Served as vice president, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing a lead drug candidate from discovery stage to Phase III development. Prior to that,?? employed by SmithKline Beecham Pharmaceuticals in sales, marketing, and business strategy positions. He has also served as vice president of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance). He is board member of RegenerAge SAPI de CV (www.regenerage.clinic/en), the Reanima Project, and member of the World Economic Forum’s Human Enhancement Council (https://www.weforum.org/